The Epidemiology Research Program (within the American Cancer Society’s Research Department) conducts, analyzes, and publishes original research on the causes and prevention of cancer. Current analyses rely primarily on the CPS-II cohort, managed and run by the Epidemiology Research Program, a group of approximately 35 full-time staff members including 9 doctoral-level and 15 masters-level personnel. CPS-II study activities include ongoing tracking and follow-up of study participants, data collection and management, data editing and analysis, and reporting in peer-reviewed journals and at scientific meetings. Each researcher biographical sketch linked below includes further details on that scientist’s research interests as well as a selection of relevant peer-reviewed publications.
- Susan M. Gapstur, PhD, MPH, Vice President
- Peter T. Campbell, PhD, Director, Tumor Repository
- Mia Gaudet, PhD, Director, Genetic Epidemiology
- Eric J. Jacobs, PhD, Strategic Director, Pharmacoepidemiology
- Marjorie McCullough, ScD, Strategic Director, Nutritional Epidemiology
- Alpa V. Patel, PhD, Strategic Director, Cancer Prevention Study-3
- Victoria L Stevens, PhD, Strategic Director, Laboratory Services
- Lauren R. Teras, PhD, Director, Hematologic Cancer Research
The primary responsibility of the analysts in the Epidemiology Research Program is to conduct epidemiologic analyses of cancer risk factors utilizing data from the Cancer Prevention Study cohorts. In collaboration with senior staff, the analysts develop and test scientific hypotheses about the potential causes of different types of cancer. They examine risk factors related to lifestyle (diet, exercise, medication use, etc.), demographics (age, race, education, etc.), genetics, and various other exposures. Statistical software is used to manage study data, compile descriptive statistics such as frequencies, means, and rates of cancer in the study populations, and to generate predictive measures of association between types of cancers and their proposed risk factors. Results from these statistical analyses are interpreted in the broader context of existing knowledge, prepared for publication in peer-reviewed journals, presented to internal and external audiences, and otherwise disseminated to appropriate professional, scientific and lay audiences in collaboration with other ACS staff.
The Biospecimen Group is responsible for tracking all biospecimens, coordinating sample selection for new projects and lab reliability analyses, processing new sample receipt data and other biospecimen-related data from CPS-II and CPS-3 participants.
Cancer Prevention Study-3 (CPS-3) Group
The American Cancer Society's Epidemiology Research Program is currently recruiting the next generation Cancer Prevention Study, CPS-3. The ultimate goal is to enroll at least 300,000 men and women from various racial/ethnic backgrounds who are between the ages of 30 and 65 years who have never been diagnosed with cancer into this long-term follow-up study. Study enrollment opportunities will take place at various venues in communities across the United States and Puerto Rico. CPS-3 will help researchers better understand the causes of cancer and how to prevent it, which will save lives and give people more of their most precious resource: time. More time with their families, more memories...and more birthdays.
Study Management Group
Study Management Group is responsible for collecting and processing data from surveys, hospital medical records, National Death Index linkage, cancer registries and other related data from CPS-II and CPS-3 participants for epidemiologic studies.